These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20383727)
21. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state. Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168 [TBL] [Abstract][Full Text] [Related]
22. Lipoprotein (a) in Behçet's disease as an indicator of disease activity and in thrombotic complications. Gürbüz O; Ozdemir Y; Coşar CB; Kural G Eur J Ophthalmol; 2001; 11(1):62-5. PubMed ID: 11284488 [TBL] [Abstract][Full Text] [Related]
23. Hemostatic parameters in Behçet's disease: a reappraisal. Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913 [TBL] [Abstract][Full Text] [Related]
24. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
25. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease. Gurgey A; Balta G; Boyvat A Blood Coagul Fibrinolysis; 2003 Feb; 14(2):121-4. PubMed ID: 12632020 [TBL] [Abstract][Full Text] [Related]
26. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease. Cosan F; Oku B; Gedar Totuk OM; Abaci N; Ustek D; Diz Kucukkaya R; Gul A Int J Rheum Dis; 2018 Dec; 21(12):2175-2179. PubMed ID: 28809090 [TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis. Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763 [TBL] [Abstract][Full Text] [Related]
28. Decreased protein S activity is related to the disease activity of Behcet's disease. Kwon SR; Lim MJ; Park SG; Moon YS; Park W Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634 [TBL] [Abstract][Full Text] [Related]
29. Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy. Mejía JC; Espinosa G; Tàssies D; Reverter JC; Cervera R Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S67-71. PubMed ID: 25068444 [TBL] [Abstract][Full Text] [Related]
30. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement. Sengül N; Demirer S; Yerdel MA; Terzioğlu G; Akin B; Gürler A; Tüzüner A World J Surg; 2000 Dec; 24(12):1584-8. PubMed ID: 11193728 [TBL] [Abstract][Full Text] [Related]
31. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis. Lenk N; Ozet G; Alli N; Coban O; Erbaşi S Int J Dermatol; 1998 Feb; 37(2):124-5. PubMed ID: 9542668 [TBL] [Abstract][Full Text] [Related]
32. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events? Martínez M; Ricart JM; Ruiz-Aja S; Rus A; Todolí J; Calvo J; Vayá A Pathophysiol Haemost Thromb; 2007; 36(1):18-22. PubMed ID: 18332610 [TBL] [Abstract][Full Text] [Related]
33. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement. Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550 [TBL] [Abstract][Full Text] [Related]
34. Behçet's disease and breast cancer: A case series study. Karatas F; Sahin S; Aytekin A; Erdem GU; Ates O; Ozisik Y; Aksoy S; Altundag K J Cancer Res Ther; 2018; 14(6):1184-1190. PubMed ID: 30488827 [TBL] [Abstract][Full Text] [Related]
35. Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. Gül A; Ozbek U; Oztürk C; Inanç M; Koniçe M; Ozçelik T Br J Rheumatol; 1996 Nov; 35(11):1178-80. PubMed ID: 8948311 [TBL] [Abstract][Full Text] [Related]
36. Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases. Korkmaz C; Kasifoglu T; Kebapçi M Joint Bone Spine; 2007 May; 74(3):245-8. PubMed ID: 17369069 [TBL] [Abstract][Full Text] [Related]
37. Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis. Ricart JM; Vaya A; Todolí J; Calvo J; Contreras MT; España F; Aznar J; Corella D Thromb Res; 2005; 115(5):399-404. PubMed ID: 15810159 [TBL] [Abstract][Full Text] [Related]
38. Venous thrombosis and relapses in patients with Behçet's disease. Descriptive analysis from Spanish network of Behçet's disease (REGEB cohort). Rodríguez-Carballeira M; Solans R; Larrañaga JR; García-Hernández FJ; Rios-Fernández R; Nieto J; Solanich X; Martínez-Valle F; Fonseca E; Muñoz FJ; Fraile G; de Escalante B; Boldova R; Hurtado R; Espinosa G; Clin Exp Rheumatol; 2018; 36(6 Suppl 115):40-44. PubMed ID: 29745871 [TBL] [Abstract][Full Text] [Related]
39. Serum homocysteine level is higher in Behçet's disease with vascular involvement. Ateş A; Aydintuğ O; Olmez U; Düzgün N; Duman M Rheumatol Int; 2005 Jan; 25(1):42-4. PubMed ID: 14586553 [TBL] [Abstract][Full Text] [Related]